Rupesh Jain
Impact in
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Dermatology top 10%
- Skin Protection and Aging
Papers in
-
- Nanoplatforms for cancer theranostics 4
- Co-authors
- Gautam Singhvi (10 shared papers)Sunil Kumar Dubey (10 shared papers)Archana Khosa (1 shared paper)Vamshi Krishna Rapalli (1 shared paper)Mangala Rao (1 shared paper)Atiya R. Faruqui (1 shared paper)Viswanathan Mohan (1 shared paper)Prem Pais (1 shared paper)
- Journals
- Molecular Pharmaceutics (1 paper)Journal of Molecular Liquids (1 paper)Pharmaceutics (1 paper)Current Drug Delivery (1 paper)Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (1 paper)
- Partner nations
- IndiaUnited Arab Emirates
In The Last Decade
Rupesh Jain
14 papers receiving 333 citations
Peers
Comparison fields: 5 of 80
- Pharmaceutical Science 48
- Dermatology 33
- Biomaterials 43
- Molecular Medicine 13
- Cardiology and Cardiovascular Medicine 51
Countries citing papers authored by Rupesh Jain
This map shows the geographic impact of Rupesh Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupesh Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupesh Jain more than expected).
Fields of papers citing papers by Rupesh Jain
This network shows the impact of papers produced by Rupesh Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupesh Jain. The network helps show where Rupesh Jain may publish in the future.
Co-authors
The 25 scholars most cited alongside Rupesh Jain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 103 | |
| 2 | 2019 | 39 | |
| 3 | 2021 | 32 | |
| 4 | Evaluation and management of hypertension. | 2007 | 28 |
| 5 | 2023 | 25 | |
| 6 | 2024 | 24 | |
| 7 | 2020 | 22 | |
| 8 | 2020 | 21 | |
| 9 | 2022 | 16 | |
| 10 | 2020 | 9 | |
| 11 | 2022 | 8 | |
| 12 | 2023 | 8 | |
| 13 | 2019 | 7 | |
| 14 | Evaluation and management of Hypertension :44:103-21 | 2007 | 4 |
About Rupesh Jain
Rupesh Jain is a scholar working on Biomedical Engineering, Molecular Biology, Pulmonary and Respiratory Medicine, Pharmaceutical Science and Dermatology, having authored 14 papers that have together received 346 indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (4 papers), Nanoplatforms for cancer theranostics (4 papers), Advancements in Transdermal Drug Delivery (3 papers), Sodium Intake and Health (2 papers), Blood Pressure and Hypertension Studies (2 papers), Advanced Drug Delivery Systems (2 papers), Skin Protection and Aging (2 papers) and Genetic and rare skin diseases. (1 paper). The work is most often cited by research in Pharmaceutical Science (48 citations), Dermatology (33 citations), Biomaterials (43 citations), Molecular Medicine (13 citations) and Cardiology and Cardiovascular Medicine (51 citations). Rupesh Jain has collaborated with scholars based in India and United Arab Emirates. Frequent co-authors include Gautam Singhvi, Sunil Kumar Dubey, Archana Khosa, Vamshi Krishna Rapalli, Mangala Rao, Atiya R. Faruqui, Viswanathan Mohan, Prem Pais, Prafulla Kerkar and Natarajan Chidambaram. Their work appears in journals such as Molecular Pharmaceutics, Journal of Molecular Liquids, Pharmaceutics, Current Drug Delivery and Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.